Corinne Espéret

A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis

Yannick Allanore, Peter K. Wung, Christina Soubrane et al. · Annals of the Rheumatic Diseases · 2020 · 108 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16

SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)

Ganesh Raghu, Luca Richeldi, Bruno Crestani et al. · European Respiratory Journal · 2018 · 99 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +13

Non-erythroid Genes Inserted on Either Side of Human HS-40 Impair the Activation of Its Natural α-Globin Gene Targets without Being Themselves Preferentially Activated

Corinne Espéret, Sandrine Sabatier, Marie‐Alice Deville et al. · Journal of Biological Chemistry · 2000 · 13 citations · Full text

Life Sciences, Genetics, Molecular Biology +11